FGP
PRVA icon

Freestone Grove Partners’s Privia Health PRVA Stock Holding History

Freestone Grove Partners’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.3M Sell
839,474
-373,868
-31% -$8.43M 0.12% 227
2025
Q4 		$28.8M Buy
1,213,342
+350,194
+41% +$8.52M 0.21% 162
2025
Q3 		$21.5M Buy
863,148
+322,426
+60% +$6.94M 0.16% 195
2025
Q2 		$12.4M Buy
+540,722
New +$12.5M 0.09% 257

Other funds holding PRVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Freestone Grove Partners's PRVA Position: Q1 2026 in Review

Freestone Grove Partners reduced its Privia Health (PRVA) stake by 31% in Q1 2026, selling an estimated $8.43M and leaving 839,474 shares worth $17.3M. The position accounts for 0.12% of the portfolio, ranked #227.

Freestone Grove Partners first reported a position in PRVA in Q2 2025 and has held it in 4 quarters since. The position peaked at $28.8M in Q4 2025. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • Freestone Grove Partners held 839,474 shares of Privia Health worth $17.3M as of Q1 2026.
  • Freestone Grove Partners sold 373,868 Privia Health shares in Q1 2026, an estimated $8.43M.
  • Privia Health made up 0.12% of Freestone Grove Partners's portfolio in Q1 2026, its #227 holding.
  • Freestone Grove Partners first reported a position in Privia Health in Q2 2025 and has held it in 4 quarters since.
  • Freestone Grove Partners's Privia Health position peaked at $28.8M in Q4 2025.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.